PortViewPortView
Hercules Capital logo

Hercules Capital (HCXZ) Stock Analysis

NYSEFinancial ServicesAsset Management

$25.20+0.00%
52-week range$25.20
$24.15$26.80

What Hercules Capital does

Hercules Capital, Inc. operates as a Business Development Company (BDC), specializing in providing capital to high-growth companies. It primarily offers venture debt, senior secured loans, and growth capital to privately held, venture capital-backed enterprises across all stages of development, from nascent startups to established businesses. The firm also selectively partners with publicly traded companies and lower middle-market firms seeking funds for acquisitions, recapitalizations, or refinancing. Hercules Capital provides a comprehensive suite of financing solutions tailored for various corporate objectives: Growth & Expansion: This includes capital extensions, management buy-outs, corporate spin-outs, financing for company, asset, or intellectual property acquisitions, and support for both domestic and international corporate expansion, vendor financing, and initiatives for revenue acceleration through sales, marketing, and manufacturing development. Asset-Based Lending: Focused on cash flow, these solutions encompass accounts receivable facilities, equipment loans or leases (for acquisition or facility build-out/expansion), and revolving lines of credit for working capital and inventory needs. Strategic & Bridge Financing: The firm supports critical transitions such as bridge financing to IPOs or M&A, technology acquisitions, dividend recapitalizations, and other investor liquidity events. It also offers cash flow financing to mitigate share price volatility, funding for competitor acquisitions, pre-IPO financing for balance sheet enhancement, public company financing for continued asset growth, short-term bridge loans, and financing for strategic and intellectual property acquisitions. Additionally, Hercules Capital structures convertible, subordinated, and mezzanine loans. The firm's primary investment strategy involves structured debt coupled with warrants, though it also participates in senior debt and, to a lesser extent, direct equity investments. It generally seeks companies that have been operational for at least 6 to 12 months prior to investment. Hercules Capital shows a strong preference for specific sectors, including technology (spanning software, hardware, digital media, security, business services), energy technology (such as clean tech, renewables, smart grid), and life sciences (including biopharmaceuticals, medical devices, and diagnostics). Educational services also fall within its investment scope. Geographically, Hercules Capital predominantly invests in U.S.-based companies, with a particular focus on the West Coast, Mid-Atlantic, Southeast, and Midwest regions, especially for software, biotech, and information services businesses. While equity investments can range from $10 million to $250 million per transaction, typical financing for companies in business services, communications, electronics, hardware, and healthcare services ranges between $1 million and $40 million. Although its portfolio mainly consists of private companies, it also holds investments in public entities. For direct equity investments, the firm may pursue a significant stake, potentially exceeding 25% of voting securities. A portion of its assets is dedicated to equipment-based loans for early-stage companies, generally up to $3 million, with an allowance of up to $15 million for specific energy technology ventures. Many of its debt instruments include an option for conversion into equity. The firm also actively co-invests with other private equity firms. Hercules Capital aims for investment exits through various avenues, including initial public offerings (IPOs), private sales of equity interests to third parties, mergers or acquisitions of the portfolio company, or buybacks of the equity position by the company or its shareholders. Investment horizons vary: structured debt with warrants typically matures within 2-7 years (averaging three years), senior debt within three years, equipment loans between three and four years, and equity-related securities between three and seven years. The company utilizes its balance sheet capital for these investments. Founded in December 2003, Hercules Capital, Inc. was formerly known as Hercules Technology Growth Capital, Inc. It is headquartered in Palo Alto, California, and maintains numerous offices across the U.S., including Boston, San Diego, New York, and Washington D.C., along with an international office in London, United Kingdom.

Key metrics

Market cap
$1.31B
P/E (TTM)
135.85
EPS (TTM)
$0.19
Beta
1.32
Dividend yield
11.01%
Revenue / share
$3.13
50-day avg
$25.20
200-day avg
$25.33
52-week high
$26.80
52-week low
$24.15
CEO
Scott Bluestein

ETFs linked to HCXZ

Broad-market and Financial Services sector ETFs an investor holding Hercules Capital is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HCXZ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HCXZ in PortView →

Frequently asked questions

What is the ticker symbol for Hercules Capital?
Hercules Capital trades under the ticker HCXZ on NYSE.
Which exchange is HCXZ listed on?
HCXZ is listed on NYSE.
What sector does Hercules Capital operate in?
Hercules Capital is classified in the Financial Services sector (Asset Management industry).
How can PortView help analyze HCXZ in a portfolio?
PortView shows HCXZ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.